Average Co-Inventor Count = 2.40
ph-index = 25
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck & Company, Inc. (136 from 4,759 patents)
2. Novira Therapeutics, Inc. (38 from 44 patents)
3. Merck Sharp & Dohme Corporation (5 from 2,362 patents)
4. Bioage Labs, Inc. (5 from 8 patents)
5. Janssen Sciences Ireland Unlimited Company (2 from 60 patents)
6. Hitgen, Inc. (1 from 7 patents)
181 patents:
1. 12215087 - Inhibitors of NLRP3 inflammasome
2. 12129251 - N-oxide inhibitors of NLRP3 inflammasome
3. 11787805 - N-oxide inhibitors of NLRP3 inflammasome
4. 11708334 - Inhibitors of NLRP3 inflammasome
5. 11702391 - Inhibitors of NLRP3 inflammasome
6. 11129834 - Combinations and methods comprising a capsid assembly inhibitor
7. 10987359 - Oxadiazepinone derivatives and methods of treating hepatitis B infections
8. 10975077 - Diazepinone derivatives and their use in the treatment of hepatitis B infections
9. 10632112 - Combination therapy for treatment of HBV infections
10. 10556904 - Derivatives and methods of treating hepatitis B infections
11. 10544141 - Derivatives and methods of treating hepatitis B infections
12. 10537580 - Azocane and azonane derivatives and methods of treating hepatitis B infections
13. 10538519 - Derivatives and methods of treating hepatitis B infections
14. 10441589 - Combinations and methods comprising a capsid assembly inhibitor
15. 10392349 - Azepane derivatives and methods of treating hepatitis B infections